Inavolisib for PIK3CA Mutated Advanced Endometrial Cancer: MITO END-4
Clinical trial NCT07522697 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07522697
- Sponsor
- National Cancer Institute, Naples
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2030-05-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.